drugset
drugset / Trial / NCT06012721

Effect of Food on the Pharmacokinetics of ORIC-114

NCT06012721 ↗

Phase 1 Completed 32 enrolled ORIC Pharmaceuticals
RandomizedCrossoverOpen-labelOther

Summary

A randomized, 2-part, 2-sequence, 2-period, open-label, crossover study evaluating the effect of food on the pharmacokinetics (PK) of ORIC-114 tablet formulation in healthy adult subjects.

Timeline

Start
2023-09-11
Primary completion
2023-11-23
Completion
2023-11-23

Drugs

EvaluationDrugModalityDoseRoute
Subject ORIC-114 Small molecule 30 mg —

Indications

No indication recorded.